The clinical importance of fibroblast growth factor 23 on advanced non-small cell lung cancer patients without druggable alterations in genes as EGFR or ALK or ROS1 Fibroblast growth factor 23 and non-small cell lung cancer
2015 ◽
Vol 46
(12)
◽
pp. 1821-1828
◽
2012 ◽
Vol 82
(1)
◽
pp. 442-447
◽
2015 ◽
2015 ◽
Vol 10
(7)
◽
pp. 1083-1090
◽
2018 ◽
Vol 37
(1)
◽
Keyword(s):
2012 ◽
Vol 12
(2)
◽
pp. 107-123
◽
2010 ◽
Vol 3
(1)
◽
pp. 23-26